The Pennine Acute Hospitals
NHS Trust Formulary
 
back
13 Skin

Dermatology services are provided by visiting consultants from Salford Royal Foundation Trust, and choice of therapy is therefore guided by SRFT's formulary. To confirm the formulary status of a product, please see http://www.srft.nhs.uk/for-professionals/formulary/
13-05-03 Drugs affecting the immune response

Adalimumab Humira®
Formulary
Link  NICE (2008) Adalimumab for the treatment of adults with psoriasis. (TA146).
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Azathioprine
Formulary
Tablets

unlicensedunlicensed indication (severe refractory eczema)
Link  UKMI Q&A: Can mothers breastfeed while taking azathioprine?
 

Cytotoxic Drug  Amber View adult BNF  View SPC online  View childrens BNF
Ciclosporin
Formulary
Capsules
Oral Solution

Must be prescribed by BRAND. (See Section 8.2.2.)

Amber View adult BNF  View SPC online  View childrens BNF
Etanercept Enbrel®
Formulary
Link  NICE TA103: Psoriasis - efalizumab and etanercept
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Infliximab Remicade®
Formulary
Link  NICE TA134: Infliximab for psoriasis
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Methotrexate
Formulary
Tablets
Injection
Link  NPSA Alert (2006): Improving compliance with oral methotrexate
 

Cytotoxic Drug  Amber View adult BNF  View SPC online  View childrens BNF
Mycophenolate mofetil
Formulary
Tablets
Capsules
Oral suspension

unlicensedunlicensed indication (severe refractory eczema)
Link  MHRA (2015): Mycophenolate mofetil: risk of hypogammaglobulinaemia and risk of bronchiectasis
Link  MHRA Safety Alert: Contraception advice for male patients
Link  MHRA Safety Alert: Pregnancy prevention advice
 

Amber View adult BNF  View SPC online  View childrens BNF
Pimecrolimus 1% Cream Elidel®
Formulary
Cream

Restricted Item Consultant Dermatologist only, in line with NICE Guidance



Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
 

Green 2 View adult BNF  View SPC online  View childrens BNF
Secukinumab Cosentyx®
Formulary
Link  GMMMG Harmonised Biologics Pathway for Ankylosing Spondylitis
Link  NICE TA407: Secukinumab for active ankylosing spondylitis
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Tacrolimus Protopic®
Formulary
0.03% Ointment
0.1% Ointment

Restricted Item Consultant Dermatologist only

Link  MHRA (2012): Tacrolimus ointment: possible risk of malignancies
Link  NICE TA82: Pimecrolimus and tacrolimus for atopic dermatitis (eczema)
 

Green 2 View adult BNF  View SPC online  View childrens BNF
Ustekinumab
Formulary
NICE and GMMMG recommend ustekinumab as an option, alone or in combination with methotrexate, for treating active psoriatic arthritis in adults only when:
• treatment with TNF alpha inhibitors is contraindicated but would otherwise be considered
• or the person has had treatment with 1 or more TNF–alpha inhibitors.

Consideration should be given to discontinuing treatment in patients who have shown no response up to 28 weeks of treatment.

Available via Patient Access Scheme: please contact pharmacy for details
Link  MHRA 2015: Ustekinumab: risk of exfoliative dermatitis
Link  NICE (2015) Ustekinumab for treating active psoriatic arthritis (TA340)
Link  NICE TA180: Psoriasis - ustekinumab
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Efalizumab Raptiva®
Non Formulary

View adult BNF  View SPC online  View childrens BNF